Hospital
John Fitzgibbon Memorial Hospital INC.
John Fitzgibbon Memorial Hospital INC. was paid $4.70M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
33Billing provider infoJOHN FITZGIBBON MEMORIAL HOSPITAL INC.
MARSHALL, MO 65340
MARSHALL, MO 65340
33aNPI1730182478assigned 05/26/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.70M
24GClaims86,873
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#36 of 74
Median peer was paid$4.44M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HARRIS, NANCY controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,778 | $1.43M | |
| 2019 | 7,342 | $985K | |
| 2020 | 7,498 | $341K | |
| 2021 | 12,007 | $146K | |
| 2022 | 18,244 | $508K | |
| 2023 | 20,984 | $728K | |
| 2024incomplete | 14,020 | $561K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 13,561 | 12,141 | $1.85M |
| Y7506 | 17% | 5,486 | 4,441 | $817K | |
| X4011 | State-specific procedure code | 6.7% | 3,259 | 2,214 | $315K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.4% | 2,083 | 1,714 | $300K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.0% | 10,427 | 8,052 | $284K |
| 80053 | Comprehensive metabolic panel | 5.2% | 8,797 | 6,789 | $246K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.4% | 1,995 | 1,831 | $161K |
| 87400 | 2.1% | 1,915 | 1,689 | $100K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.8% | 4,652 | 3,165 | $87K |
| 81003 | 1.5% | 10,568 | 7,340 | $69K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.5% | 326 | 259 | $68K |
| 87428 | 1.3% | 3,414 | 2,976 | $59K |
60 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 701 | $34K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,836 | $28K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,752 | $27K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 389 | $25K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,203 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 847 | $21K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 466 | $17K |
| 62323 | <1% | 124 | $14K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 129 | $14K |
| X4006 | <1% | 55 | $13K | |
| 80306 | <1% | 972 | $13K | |
| 87807 | <1% | 295 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 988 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 158 | $11K |
| Y7507 | <1% | 100 | $9K | |
| X4003 | <1% | 1,090 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 671 | $8K |
| 95819 | <1% | 49 | $7K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 280 | $6K |
| 80061 | Lipid panel | <1% | 660 | $5K |
| 86780 | <1% | 394 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 38 | $4K |
| 77002 | <1% | 75 | $4K | |
| 87430 | <1% | 472 | $4K | |
| 84439 | <1% | 237 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 351 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 198 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 109 | $2K |
| 82607 | <1% | 256 | $2K | |
| 83880 | <1% | 84 | $2K | |
| 73110 | <1% | 37 | $2K | |
| 87081 | <1% | 406 | $1K | |
| 84484 | <1% | 259 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 21 | $876.88 |
| 73610 | <1% | 15 | $819.07 | |
| 84145 | <1% | 64 | $793.60 | |
| 86140 | <1% | 433 | $686.87 | |
| 81025 | <1% | 177 | $682.65 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 31 | $551.41 |
| 83605 | <1% | 139 | $548.34 | |
| 87070 | <1% | 172 | $514.50 | |
| 85027 | <1% | 68 | $361.23 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 25 | $221.32 |
| 93041 | <1% | 13 | $171.40 | |
| 82550 | <1% | 61 | $165.80 | |
| 84481 | <1% | 19 | $159.47 | |
| 82077 | <1% | 23 | $131.31 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 15 | $57.78 |
| 86762 | <1% | 15 | $34.53 | |
| 87340 | <1% | 15 | $24.78 | |
| 86850 | <1% | 15 | $23.43 | |
| J3490 | Unclassified drugs | <1% | 137 | $12.40 |
| 86901 | <1% | 15 | $7.17 | |
| 86900 | <1% | 15 | $7.17 | |
| 81002 | <1% | 13 | $3.13 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 33 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 57 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 39 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 51 | $0.00 |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARRIS, NANCY (CFO/COO)
Parent organizationJOHN FITZGIBBON MEMORIAL HOSPITAL INC.
| Provider | Location | Paid |
|---|---|---|
| John Fitzgibbon Memorial Hospital INC. | Marshall, MO | $793K |
| John Fitzgibbon Memorial Hospital, INC. | Marshall, MO | $790K |
| John Fitzgibbon Memorial Hospital INC. | Slater, MO | $180K |
| John Fitzgibbon Memorial Hospital | Marshall, MO | $132K |
| Westport Public Schools | Westport, CT | $131K |
| John Fitzgibbon Memorial Hospital INC | Marshall, MO | $129K |
| John Fitzgibbon Memorial Hospital INC | Marshall, MO | $122K |
| John Fitzgibbon Memorial Hospital INC | Fayette, MO | $98K |
| John Fitzgibbon Memorial Hospital INC | Marshall, MO | $78K |
| John Fitzgibbon Memorial Hospital, INC. | Brunswick, MO | $74K |
| John Fitzgibbon Memorial Hospital, INC. | Marshall, MO | $67K |
| John Fitzgibbon Memorial Hospital INC | Marshall, MO | $39K |
| John Fitzgibbon Memorial Hospital, INC. | Marshall, MO | $38K |
| John Fitzgibbon Memorial Hospital INC | Marshall, MO | $22K |
| John Fitzgibbon Memorial Hospital, INC | Marshall, MO | $22K |
| John Fitzgibbon Memorial Hospital INC. | Marshall, MO | $3K |
| John Fitzgibbon Memorial Hospital, INC. | Slater, MO | $473.90 |
| Charlotte Pain Management Center INC | Port Charlotte, FL | $387.11 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.